Tabiat’s SaaS platform for AI focused remote patient monitoring improves patient care, allows doctors to provide better care for more patients and reduces the number and cost of hospitalizations. As an AI company, our platform feeds data into our battle-tested ML pipeline which allows us to build ML models to predict changes in health, hospitalizations or even candidacy for drugs. Our 3 pilot programs at 4 major hospitals in the GTA, validated our platform with 20+ doctors and 350+ patients and demonstrated our ability to build ML models that work in the real world. With an intial focus on COPD, which over 16 million Americans suffer from and is associated with $15B per year in hospitalization costs alone, Tabiat aims to launch their platform in the States in early Q1 2023.